U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C37H56O10
Molecular Weight 660.8345
Optical Activity UNSPECIFIED
Defined Stereocenters 18 / 18
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CIMIRACEMOSIDE N

SMILES

C[C@@H]1C[C@]2(OC[C@]3(C)O[C@H]23)O[C@H]4C[C@@]5(C)[C@@H]6CC[C@@H]7[C@]8(C[C@@]68C[C@@H](OC(C)=O)[C@]5(C)[C@@H]14)CC[C@H](O[C@@H]9OC[C@H](O)[C@H](O)[C@H]9O)C7(C)C

InChI

InChIKey=GCMGJWLOGKSUGX-GVGYZBMQSA-N
InChI=1S/C37H56O10/c1-18-12-37(30-33(6,47-30)17-43-37)46-21-13-32(5)23-9-8-22-31(3,4)24(45-29-28(41)27(40)20(39)15-42-29)10-11-35(22)16-36(23,35)14-25(44-19(2)38)34(32,7)26(18)21/h18,20-30,39-41H,8-17H2,1-7H3/t18-,20+,21+,22+,23+,24+,25-,26+,27+,28-,29+,30+,32+,33+,34-,35-,36+,37+/m1/s1

HIDE SMILES / InChI

Description

cimiracemoside N is a triterpene glycoside which can be isolated from the roots of Cimicifuga racemosa (Black Cohosh). Black Cohosh is consumed as a natural dietary supplement for the treatment of menopause symptoms.

Originator

University of Illinois
6
Curator's Comment: Collaborative Research in the Pharmaceutical Sciences (PCRPS, M/C 877), and UIC/ NIH Center for Botanical Dietary Supplements Research,

Approval Year

Unknown
149124
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Black cohosh (Cimicifuga spp.) for menopausal symptoms.
2012-09-12
Cimiracemosides I-P, new 9,19-cyclolanostane triterpene glycosides from Cimicifuga racemosa.
2002-10

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Curator's Comment: Related cimiracemosides (A-H) were found to modulate GABA induced currents through GABA-A ion channel, but cimiracemoside D (compound 7) was not tested / not active in this assay. (https://www.ncbi.nlm.nih.gov/pubmed/21082802)
Unknown
Name Type Language
CIMIRACEMOSIDE N
Common Name English
CIMIRACEMOSIDE N, (-)-
Preferred Name English
.ALPHA.-L-ARABINOPYRANOSIDE, (3.BETA.,12.BETA.,16.BETA.,23S,24S,25S)-12-(ACETYLOXY)-16,23:23,26:24,25-TRIEPOXY-9,19-CYCLOLANOSTAN-3-YL
Systematic Name English
Code System Code Type Description
CAS
473554-78-8
Created by admin on Mon Mar 31 23:29:08 GMT 2025 , Edited by admin on Mon Mar 31 23:29:08 GMT 2025
PRIMARY
PUBCHEM
21591918
Created by admin on Mon Mar 31 23:29:08 GMT 2025 , Edited by admin on Mon Mar 31 23:29:08 GMT 2025
PRIMARY
FDA UNII
9259Y53BCI
Created by admin on Mon Mar 31 23:29:08 GMT 2025 , Edited by admin on Mon Mar 31 23:29:08 GMT 2025
PRIMARY
SUBSTANCE RECORD
Structure of CIMIRACEMOSIDE N
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966